Luis A Moran (Luis A Morán)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Atrial Fibrillation

Top Venues

Thrombosis and haemostasis

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Richard John Buka, Samantha Jayne Montague, Luis A Moran, Eleyna M Martin, Alexandre Stephane Slater, Stephen P Watson, Phillip Lindsay Ross Nicolson
PF4 activates the c-Mpl-Jak2 pathway in platelets. Blood (2023)
Luis A Moran, Ying Di, Marcin A Sowa, Lidia Hermida-Nogueira, María N Barrachina, Eleyna Martin, Joanne C Clark, Todd H Mize, Johannes Andreas Eble, David Moreira, Alice Y Pollitt, María I Loza, Eduardo Domínguez, Stephen P Watson, Angel Garcia
Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist. Thrombosis and haemostasis 122 (8) (2022)
Yam Fung Hilaire Cheung, Luis A Moran, Albert Sickmann, Johan W M Heemskerk, Angel Garcia, Stephen P Watson
Inhibition of Src but not Syk causes weak reversal of GPVI-mediated platelet aggregation measured by light transmission aggregometry. Platelets 33 (8) (2022)
María N Barrachina, Irene Izquierdo, Lidia Hermida-Nogueira, Luis A Moran, Amparo Pérez, Ana B Arroyo, Nuria García-Barberá, Rocío González-Conejero, Sara Troitiño, Johannes A Eble, José Rivera, Constantino Martínez, María I Loza, Eduardo Domínguez, Angel Garcia
The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential. International journal of molecular sciences 22 (7) (2021)
Eleyna M Martin, Malou Zuidscherwoude, Luis A Moran, Ying Di, Angel García, Stephen P Watson
The structure of CLEC-2: mechanisms of dimerization and higher-order clustering. Platelets 32 (6) (2021)
Foteini-Nafsika Damaskinaki, Luis A Moran, Angel Garcia, Barrie Kellam, Steve P Watson
Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2. Platelets 32 (6) (2021)